RobertSDiPaolaMD

Oncology • Lexington, KY

Professor of Medicine, UMDNJ-RW Johnson Medical School

Join to view full profile

Dr. DiPaola is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. DiPaola's full profile

Already have an account?

Office
UK Rose St
# 800
Lexington, KY 40536
Phone+1 859-257-1000

Fax+1 859-323-2039

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1991 - 1994
Duke University HospitalResidency, Internal Medicine, 1988 - 1991
University of Utah School of MedicineClass of 1988

Certifications & Licensure

KY State Medical License 2016 - 2025
NJ State Medical License 1994 - 2017
PA State Medical License 1991 - 1994
NC State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
America's Top Doctors Castle Connolly, 2011-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2010-2013
NJ.com Top Doctors Castle Connolly, 2009
Join now to see all

Clinical Trials

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2001 Apr 05
Completed
Phase 2
Ixabepilone in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia Start of enrollment: 2004 May 01
Terminated
Phase 2
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2002 Nov 01
Terminated
Phase 2
Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2007 Sep 01
Terminated
Phase 2
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer Start of enrollment: 2006 Nov 01
Terminated
Phase 1, Phase 2
R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2009 Jul 01
Completed
Phase 2
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration Start of enrollment: 2009 Jun 01
Completed
Phase 1, Phase 2
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy Start of enrollment: 2011 Jan 01
Completed
Phase 2
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 Start of enrollment: 2012 Dec 07
Completed
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer Start of enrollment: 2013 Jun 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasect...
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta K Pal, Michael R Pins
Journal of Clinical Oncology. 2024-06-10
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
Bradley C Carthon, Se Eun Kim, David F McDermott, Janice P Dutcher, Maneka Puligandla
Clinical Genitourinary Cancer. 2023-10-01
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
Wendy J Bottinor, Yael Flamand, Naomi B Haas, Anne M ONeill, Robert S DiPaola
Journal of the National Comprehensive Cancer Network. 2023-07-01

Press Mentions

Kentucky Is Facing a Health Care Shortage. UK’s $2B Plan Hopes To Fill the GapApril 27th, 2023
$1.6M Gift to Markey Will Establish Endowed Chair in Gynecologic OncologyFebruary 6th, 2023
UK Launches Website for New Health Education BuildingJune 8th, 2022
Join now to see all

Grant Support

Early Clinical Trials Of New Anti-Cancer Agents With Phase I Emphasis (U01)National Cancer Institute2008–2012
Cancer Center Support GrantNational Cancer Institute2008–2012
Retinoid, Interferon And Taxol Effects In Breast CancerNational Cancer Institute1998–1999
To Abrogate BCL-2 Mediated Resist In Prostate CancerNational Cancer Institute1997–1998

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

RobertSDiPaolaMD

Dr. DiPaola is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.